Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Harrow
HROW
$1.45B
| $376K | ﹤0.01% |
55,666
| – | – |
|
|
AGRX
3177
DELISTED
Agile Therapeutics
AGRX
| $376K | ﹤0.01% |
90
+4
| +5% | +$21.6K |
|
3178
C&F Financial
CFFI
$268M
| $374K | ﹤0.01% |
8,423
| – | – |
|
|
GTT
3179
DELISTED
GTT Communications, Inc.
GTT
| $374K | ﹤0.01% |
204,243
-5,082
| -2% | -$15.5K |
|
3180
Capital Bancorp
CBNK
$608M
| $372K | ﹤0.01% |
19,268
-1,995
| -9% | -$32.7K |
|
3181
EVI Industries
EVI
$181M
| $372K | ﹤0.01% |
12,926
+1,098
| +9% | +$38.4K |
|
3182
Smith & Nephew
SNN
$13.3B
| $371K | ﹤0.01% |
9,784
+485
| +5% | +$20K |
|
3183
First Northwest Bancorp
FNWB
$109M
| $369K | ﹤0.01% |
22,187
| – | – |
|
3184
SAP
SAP
$212B
| $368K | ﹤0.01% |
3,000
-331
| -10% | -$42K |
|
3185
Meridian
MRBK
$234M
| $367K | ﹤0.01% |
28,222
| – | – |
|
|
ENZ
3186
DELISTED
Enzo Biochem, Inc.
ENZ
| $365K | ﹤0.01% |
106,009
| – | – |
|
3187
Exicure
XCUR
$10.2M
| $361K | ﹤0.01% |
1,103
+206
| +23% | +$70.9K |
|
3188
Cabaletta Bio
CABA
$437M
| $360K | ﹤0.01% |
32,390
| – | – |
|
3189
X4 Pharmaceuticals
XFOR
$375M
| $359K | ﹤0.01% |
1,389
| – | – |
|
3190
Chemung Financial Corp
CHMG
$393M
| $357K | ﹤0.01% |
8,519
| – | – |
|
|
BFIN
3191
DELISTED
BankFinancial
BFIN
| $355K | ﹤0.01% |
34,372
+3,231
| +10% | +$31.3K |
|
3192
Eastern Company
EML
$143M
| $355K | ﹤0.01% |
13,236
| – | – |
|
3193
First Community Corp
FCCO
$321M
| $355K | ﹤0.01% |
17,786
| – | – |
|
3194
BGSF Inc
BGSF
$59.5M
| $353K | ﹤0.01% |
25,172
+2,771
| +12% | +$38.8K |
|
|
PVLA
3195
Palvella Therapeutics
PVLA
$1.99B
| $353K | ﹤0.01% |
1,715
+117
| +7% | +$25.6K |
|
3196
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $352K | ﹤0.01% |
6,609
-2,140
| -24% | -$117K |
|
3197
Genprex
GNPX
$3.02M
| $351K | ﹤0.01% |
2
| – | – |
|
3198
Pioneer Bancorp
PBFS
$432M
| $351K | ﹤0.01% |
30,066
| – | – |
|
|
TYME
3199
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $351K | ﹤0.01% |
196,807
+34,450
| +21% | +$71.5K |
|
3200
Aprea Therapeutics
APRE
$7.68M
| $350K | ﹤0.01% |
3,428
-171
| -5% | -$19.9K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.